|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/16 | |
| A61K 9/20 | |||
| A61K 38/26 |
| (11) | Number of the document | 2863895 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13729743.8 |
| Date of filing the European patent application | 2013-06-19 | |
| (97) | Date of publication of the European application | 2015-04-29 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/062751 |
| Date | 2013-06-19 |
| (87) | Number | WO 2013/189988 |
| Date | 2013-12-27 |
| (30) | Number | Date | Country code |
| 12172739 | 2012-06-20 | EP | |
| 201261662456 P | 2012-06-21 | US |
| (72) |
BJERREGAARD, Simon, DK
SAUERBERG, Per, DK
NIELSEN, Flemming Seier, DK
PEDERSEN, Betty Lomstein, DK
SKIBSTED, Erik, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | TABLET FORMULATION COMPRISING A PEPTIDE AND A DELIVERY AGENT |
| TABLET FORMULATION COMPRISING A PEPTIDE AND A DELIVERY AGENT |